Gland Pharma Limited (BSE: 543245 I NSE: GLAND), a generic injectable-focused pharmaceutical company, today announced that Srinivas Sadu, the incumbent Managing Director (MD) and CEO, has been appointed as Executive Chairman and CEO of the company, effective June 10, 2024. Srinivas Sadu, a seasoned professional with
FY2024 Performance Highlights Highest ever full-year Revenue of ₹40,555 million in FY24, up 14.4% YoY Highest ever full-year EBITDA of ₹7,477 million in FY24, up 77.6% YoY US business achieved top end of $250 million revenue outlook for FY24, grew by 11.8% YoY Net
In a recent announcement, 8chili, a pioneering deep tech company based in San Ramon, California and Bangalore, India, has announced a significant investment from strategic investor and mentor Karna D Shinde. This investment marks a milestone in 8chili's journey as it continues to lead the
The appointment is effective as of May 16, 2024. In her new role, Annapurna will lead the Company in India, ensuring patient access to its highly innovative medicines and vaccines, and advancing valuable collaborations to contribute to the growing domestic healthcare and pharmaceutical market. (TSE:4502/NYSE:TAK) Takeda Biopharmaceuticals
Sevelamer Carbonate Tablets approval consolidates the Company's position in the Sevelamer segment by complementing the existing approval of Sevelamer for Oral Suspension Strides Pharma Science Limited (Strides) today announced that its step-down wholly owned subsidiary, Strides Pharma Global Pte. Limited, Singapore, has received approval
By Rajiv Nath, Forum Coordinator, Association of Indian Medical Device Industry (AiMeD), New Delhi. The potential of the Indian medical devices industry is immense. With the implementation of enabling measures such as streamlining regulations, achieving self-reliance in domestic production and global competitiveness is very much within our
IPO comprises a fresh issue of 45,84,000 equity shares with a face value of Rs. 10 each In December 2023, Nephro Care India Limited successfully closed the pre-IPO funding round, which saw the participation of banking veteran and former chairman of HDFC Ltd, Deepak
Ukrainian marketing approvals for paclitaxel, oxaliplatin and irinotecan mark a significant milestone in the company’s global expansion strategy Venus Remedies is among the largest Indian exporters of these drugs Ukraine is among the largest countries in Europe and its pharmaceutical market has been witnessing
Emerges as the ONLY Healthcare Marketing Platform that ensures Real-Time Programmatic message delivery across POC platforms triggered by clinical data, AT SCALE The largest global marketing platform to reach 5 M+ HCPs across 25+ countries through 4000+ marketing campaigns Doceree, the leading global healthcare
Indian pharma companies are incorporating AI algorithms into their R&D operations, clinical trials and streamlining processes Firms deploying GenAI are seeing reduction in early-stage drug development costs, and improvement in operational efficiencies EY Parthenon (EY-P), the leading strategy consulting firm, in partnership with BioAsia,
